US 9353094
Substituted quinoxalines as kinase inhibitors
granted A61PA61P25/00A61P29/00
Quick answer
US patent 9353094 (Substituted quinoxalines as kinase inhibitors) held by The Board of Regents of the University of Texas System expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P25/00, A61P29/00, A61P35/00